Randel William Woodgrift - May 4, 2022 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Signature
/s/ Randel William Woodgrift by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
May 4, 2022
Transactions value $
-$1,646,503
Form type
4
Date filed
5/5/2022, 06:12 PM
Previous filing
Apr 5, 2022
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $1.07M +24K +50.15% $44.40 71.9K May 4, 2022 Direct
transaction ABT Common shares without par value Sale -$2.71M -24K -33.4% $113.00 47.9K May 4, 2022 Direct F1
holding ABT Common shares without par value 3.32K May 4, 2022 Profit Sharing Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -24K -45.05% $0.00 29.3K May 4, 2022 Common Shares 24K $44.40 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.00 to $113.06, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 Balance in the Abbott Laboratories Stock Retirement Trust as of May 4, 2022.
F3 Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.